Cys1 - cystin 1 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 690489
Summary
Predicted to enable chromatin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of transcription, DNA-templated. Predicted to act upstream of or within animal organ development and regulation of transcription, DNA-templated. Predicted to be located in several cellular components, including cytoskeleton; cytosol; and membrane raft. Orthologous to human CYS1 (cystin 1). [provided by Alliance of Genome Resources, Apr 2022]
Cys1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001109597.4 | NP_001103067.1 | cystin-1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cystin-1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0090 | Calcitonin (salmon) | Agonist | 99.96% | Unkown |
| HY-B1811 | Vasopressin | 99.65% | Yes | |
| HY-P0049 | Argipressin | Agonist | 98.71% | Unkown |
| HY-P0004 | Lysipressin | Activator | 99.22% | Unkown |
| HY-A0182 | Felypressin | Agonist | 99.74% | Unkown |
| HY-P0083 | Ornipressin | Agonist | 99.87% | Unkown |
| HY-17584A | Linaclotide acetate | Agonist | 98.75% | Unkown |
| HY-P0049A | Argipressin diacetate | / | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-W539944 | Argipressin acetate | 99.16% | Phase 4 | |
| HY-A0182A | Felypressin acetate | Agonist | 98.90% | Phase 4 |
| HY-P5533 | CRT | 99.76% | Phase 4 | |
| HY-P3448 | Certepetide | Activator | 99.80% | Phase 2 |
| HY-106302 | Duramycin | 99.72% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(95)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0202 | Endothelin 1 (swine, human) | Activator | 99.12% | Unkown |
| HY-P0256 | Apamin | Inhibitor | 99.96% | Unkown |
| HY-P0204A | Endothelin-3, human, mouse, rabbit, rat TFA | 99.57% | Unkown | |
| HY-P4860 | Adropin (34-76) (human, mouse, rat) | 98.23% | Unkown | |
| HY-P0202A | Endothelin 1 (swine, human) TFA | 99.77% | Unkown | |
| HY-P5322 | Thrombospondin (TSP-1)-derived CD36 binding motif | 99.58% | Unkown | |
| HY-P1408 | Obtustatin | 99.94% | Unkown | |
| HY-P1206 | CH 275 | Agonist | 99.52% | Unkown |
| HY-P1408A | Obtustatin triacetate | Inhibitor | 99.97% | Unkown |
| HY-P3226 | JB-1 | 99.63% | Unkown | |
| HY-P3561A | Agouti-related Protein (AGRP) (83-132) Amide (human) TFA | Inhibitor | 96.96% | Unkown |
| HY-P2526 | LyP-1 | 99.68% | Unkown | |
| HY-P11474 | FZ1 peptide | 99.92% | Unkown | |
| HY-P0207A | Endothelin-2 (49-69), human TFA | Ligand | 99.21% | Unkown |
| HY-P0204 | Endothelin-3, human, mouse, rabbit, rat | 97.58% | Unkown | |
| HY-17571F | Biotin-Oxytocin | 99.95% | Unkown | |
| HY-P10235 | Cyclic AC253 | Antagonist | 99.83% | Unkown |
| HY-P10557 | DAG peptide | 99.88% | Unkown | |
| HY-P4605A | (Ile8)-Oxytocin acetate | 99.65% | Unkown | |
| HY-P0256A | Apamin TFA | Inhibitor | 97.49% | Unkown |
| HY-P11354A | THR-123 TFA | / | Unkown | |
| HY-P4678 | (Phe2,Orn8)-Oxytocin | Agonist | 99.55% | Unkown |
| HY-102029 | Sarafotoxin S6c | Agonist | 98.19% | Unkown |
| HY-172275A | DSPE-PEG2000-Cys-SRNLIDC (Disulfide bridge: Cys1-Cys8) | 95.20% | Unkown | |
| HY-P10934 | LXY3 | Inhibitor | 98.33% | Unkown |
| HY-P10383 | SPSB2-iNOS inhibitory cyclic peptide-1 | 99.81% | Unkown | |
| HY-P2538 | Big Endothelin-1 (1-38), human | Agonist | 99.23% | Unkown |
| HY-P3215 | Oxytocin parallel dimer | Activator | 98.29% | Unkown |
| HY-P4605 | (Ile8)-Oxytocin | 99.65% | Unkown | |
| HY-P0083A | Ornipressin acetate | Agonist | 99.63% | Unkown |
| HY-P0207 | Endothelin-2 (49-69), human | Ligand | 99.86% | Unkown |
| HY-P11094 | Tet1-Cys peptide | 99.13% | Unkown | |
| HY-P11143 | IL4RPep-1 | Inhibitor | / | Unkown |
| HY-P11143A | IL4RPep-1 acetate | 98.61% | Unkown | |
| HY-P1463 | Calcitonin, eel | / | Unkown | |
| HY-P1463A | Calcitonin, eel TFA | 99.91% | Unkown | |
| HY-P1574 | [Arg8]-Vasotocin | / | Unkown | |
| HY-P1574A | [Arg8]-Vasotocin TFA | 98.41% | Unkown | |
| HY-P1789A | CTTHWGFTLC, CYCLIC TFA | Inhibitor | 98.52% | Unkown |
| HY-P3215A | Oxytocin parallel dimer TFA | Activator | 98.10% | Unkown |
| HY-P4205 | Aminopeptidase N Ligand (CD13) NGR peptide | Inhibitor | 99.54% | Unkown |
| HY-P4990 | Pro8-Oxytocin | Activator | 99.68% | Unkown |
| HY-P4990A | Pro8-Oxytocin TFA | Activator | 99.68% | Unkown |
| HY-P0090S | Calcitonin-13C6,15N4 (salmon) TFA | Agonist | / | Unkown |
| HY-172275 | DSPE-PEG1000-Cys-SRNLIDC (Disulfide bridge: Cys1-Cys8) | / | Unkown | |
| HY-P0038 | MK-852 | Antagonist | / | Unkown |
| HY-P0090A | Calcitonin (salmon) acetate | Agonist | / | Unkown |
| HY-P10237 | Calcitonin (chicken) | Modulator | / | Unkown |
| HY-P10328 | Vasoactive intestinal contractor | Inhibitor | / | Unkown |
| HY-P10383A | SPSB2-iNOS inhibitory cyclic peptide-1 TFA | / | Unkown | |
| HY-P10693 | CZEN-002 | Inhibitor | / | Unkown |
| HY-P10698 | VH-N412 | / | Unkown | |
| HY-P10826 | PD-1/PD-L1 inhibitory peptide C8 | Inhibitor | / | Unkown |
| HY-P10835 | LAG-3 cyclic peptide inhibitor C25 | Inhibitor | / | Unkown |
| HY-P10837 | LAG-3 cyclic peptide inhibitor 12 | Inhibitor | / | Unkown |
| HY-P10924 | Roseltide rT1 | Inhibitor | / | Unkown |
| HY-P11246 | A13:B7-24-GG | Agonist | / | Unkown |
| HY-P11264 | Cyclic peptide P1-1 | / | Unkown | |
| HY-P11354 | THR-123 | / | Unkown | |
| HY-P11408 | [D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) | Agonist | / | Unkown |
| HY-P11588 | KBP-042 | Activator | / | Unkown |
| HY-P11610 | KBP-089 | Agonist | / | Unkown |
| HY-P11612 | ATS-9R | / | Unkown | |
| HY-P11745 | CGSPGWVRC | / | Unkown | |
| HY-P11762 | CKGGRAKDC (Disulfide bridge: Cys1-Cys9) | / | Unkown | |
| HY-P11814 | cTMTP1 | / | Unkown | |
| HY-P11816 | DOTA-cTMTP1 | / | Unkown | |
| HY-P11823 | FAPα/DPP4 flurogenic substrate-1 | / | Unkown | |
| HY-P11827 | C11 peptide-1 | Inhibitor | / | Unkown |
| HY-P1371 | Pseudo RACK1 | Agonist | / | Unkown |
| HY-P1372 | PKC ζ pseudosubstrate | Inhibitor | / | Unkown |
| HY-P1719 | Recanaclotide | / | Unkown | |
| HY-P1789 | CTTHWGFTLC, CYCLIC | Inhibitor | / | Unkown |
| HY-P2005 | Malformin C | / | Unkown | |
| HY-P2496 | Endothelin 1 (swine, human), Alexa Fluor 488-labeled | / | Unkown | |
| HY-P2539 | Big Endothelin-1 (1-39), porcine | Agonist | / | Unkown |
| HY-P3171 | Acetyl-(Cys4,D-Phe7,Cys10)-a-MSH (4-13) | / | Unkown | |
| HY-P3433 | Sarafotoxin S6b | Agonist | / | Unkown |
| HY-P3561 | Agouti-related Protein (AGRP) (83-132) Amide (human) | Antagonist | / | Unkown |
| HY-P3563 | [Lys4] Sarafotoxin S6c | Agonist | / | Unkown |
| HY-P3565 | Sarafotoxin S6d | / | Unkown | |
| HY-P3571 | [Ala2] Endothelin-3, human | / | Unkown | |
| HY-P4320 | Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge: Cys1-Cys10) | Antagonist | / | Unkown |
| HY-P4678A | (Phe2,Orn8)-Oxytocin acetate | Agonist | / | Unkown |
| HY-P4994 | Val9-Oxytocin | Antagonist | / | Unkown |
| HY-P5010 | (D-Arg8)-Inotocin | Antagonist | / | Unkown |
| HY-P5017 | (Val3,Pro8)-Oxytocin | Agonist | / | Unkown |
| HY-P5130 | Big endothelin-1 (rat 1-39) | Ligand | / | Unkown |
| HY-P5140 | ω-Tbo-IT1 | Inhibitor | / | Unkown |
| HY-P5568 | Siamycin III | Inhibitor | / | Unkown |
| HY-P5738 | Palicourein | Inhibitor | / | Unkown |
| HY-P5907 | Helianorphin-19 | Activator | / | Unkown |
| HY-RS03493 | CYS1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-P3448S | Certepetide-13C6,15N2 | Activator | / | Unkown |
| HY-P3448S1 | Certepetide-13C2,15N | Activator | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service